Table 2 Relation among the four quartiles of IGFBP-3 promoter methylation by qMSP analysis with IGFBP-3 expression and clinicopathological features in OEC patients.
From: Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma
Quartiles | IGFBP-3methylation (% range) | Number of patients (%) | ||||
|---|---|---|---|---|---|---|
Low IGFBP-3 | Advanced stage | Higher grade | Patients with recurrent tumor | Patients expired | ||
First | 0.01 -- 1.07 | 1 (10) | 4 (40) | 4 (40) | 4 (40) | 2 (20) |
Second | 1.12 -- 2.83 | 1 (10) | 1 (10) | 5 (50) | 2 (20) | 2 (20) |
Third | 3.10 -- 6.36 | 5 (50) | 5 (50) | 9 (90) | 5 (50) | 5 (50) |
fourth | 6.88 -- 59.79 | 7 (70) | 6 (60) | 7 (70) | 5 (50) | 4 (40) |